CompletedNCT00770744
What is this study about?Researchers compared Zicronapine and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In FranceSchizophreniaMedication studyAges 18–65
- Countries
- France, Czechia, China, + 5 others
- Sponsor
- H. Lundbeck A/S
CompletedNCT00812461
What is this study about?Researchers compared Nalmefene and placebo to find out how the approaches affected alcohol use in people with alcohol dependence.
This study has finished and is no longer accepting participants.
In FranceMental healthMedication studyAges 18+
- Countries
- France, Belgium, Czechia, + 4 others
- Sponsor
- H. Lundbeck A/S
CompletedNCT02348073
Official study titleEfficacy of Phosphatidylserine Enriched With Polyunsaturated n-3 Fatty Acid Supplementation on Attention Deficit Disorders in Children With Epilepsy. A Randomized Double-blind Placebo-controlled Trial
This study has finished and is no longer accepting participants.
In FranceADHDMedication studyAges 6–16
- Countries
- France
- Sponsor
- Hospices Civils de Lyon
CompletedNCT03045016
Official study titlePreliminary Study About the Efficacy of an α1 Blocker (Prazosin) in Preventing the Occurrence of Post-traumatic Stress Disorder (PTSD) in Patients With Acute Stress
This study has finished and is no longer accepting participants.
In FrancePTSDMedication studyAges 18–65
- Countries
- France
- Sponsor
- Hospices Civils de Lyon
CompletedNCT00810667
What is this study about?Researchers compared Lu AE58054 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In FranceSchizophreniaMedication studyAges 18–65
- Countries
- France, Belgium, Germany, + 5 others
- Sponsor
- H. Lundbeck A/S
CompletedNCT03653858
Official study titleControlled Randomized Clinical Trial to Assess Efficacy of Deep Brain Stimulation (DBS) of the slMFB in Patients With Treatment Resistant Major Depression
This study has finished and is no longer accepting participants.
In FranceDepressionDevice studyAges 20–75
- Countries
- France, Germany
- Sponsor
- University Hospital Freiburg
CompletedNCT00735709
What is this study about?Researchers compared Vortioxetine and placebo to find out how the approaches affected depression symptoms in adults with depression.
This study has finished and is no longer accepting participants.
In FranceDepressionMedication studyAges 18–75
- Countries
- France, Australia, United Kingdom, + 12 others
- Sponsor
- Takeda
Active Not RecruitingNCT05711940
Official study titleA Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression
This study is no longer accepting new participants.
In FranceDepressionMedication studyAges 18+
- Countries
- France, United States, Canada, + 9 others
- Sponsor
- COMPASS Pathways